Abstract

The Michigan Institute for Clinical & Health Research (MICHR) recognizes the need for a highly-skilled, diverse workforce that can conduct impactful clinical and translational research that improves health. Since the inception of MICHR, the development of a diverse translational workforce has been a consistent priority. The ?crown jewel? of our efforts has been the KL2 program, which has attracted and developed exceptional scholars. Since the inception of MICHR, KL2 scholars (n=36) have published >1,000 peer-reviewed publications (median=21) and received >$155M in grant support as principal investigators (>$4 million per scholar). Importantly, 97% of all KL2 graduates have remained in clinical and translational research and 85% of the 2006-2011 cohorts have been successfully promoted. We now propose to improve this program with enhanced leadership skills through a new Career Development Academy, career development tracking with electronic portfolios, formal mentorship training for KL2 mentors and scholars, expanded internship and externship opportunities, and a stronger network of support as our KL2 scholars transition to independence. MICHR?s goal is the creation of greater positive impact through training and mentoring a new generation of KL2 scholars.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Mentored Career Development Award (KL2)
Project #
1KL2TR002241-01
Application #
9414515
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Talbot, Bernard
Project Start
2017-06-01
Project End
2022-02-28
Budget Start
2017-06-01
Budget End
2018-02-28
Support Year
1
Fiscal Year
2017
Total Cost
$1,382,859
Indirect Cost
$99,101

  Institution

Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109

  Publications

Haffajee, Rebecca L; Bohnert, Amy S B; Lagisetty, Pooja A (2018) Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment. Am J Prev Med 54:S230-S242
Haffajee, Rebecca L; Frank, Richard G (2018) Making the Opioid Public Health Emergency Effective. JAMA Psychiatry 75:767-768
Tapper, Elliot B; Kanwal, Fasiha; Asrani, Sumeet K et al. (2018) Patient-reported outcomes in cirrhosis: A scoping review of the literature. Hepatology 67:2375-2383
Parikh, Neehar D; Chang, Yu-Hui; Tapper, Elliot B et al. (2018) Outcomes of Patients With Cirrhosis Undergoing Orthopedic Procedures: An Analysis of the Nationwide Inpatient Sample. J Clin Gastroenterol :
Thomson, Mary J; Tapper, Elliot B; Lok, Anna S F (2018) Dos and Don'ts in the Management of Cirrhosis: A View from the 21st Century. Am J Gastroenterol 113:927-931
Callaghan, Brian C; Xia, Rong; Reynolds, Evan et al. (2018) Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists. Clin Neurophysiol 129:654-662
Burton, Cynthia Z; Ryan, Kelly A; Kamali, Masoud et al. (2018) Psychosis in bipolar disorder: Does it represent a more ""severe"" illness? Bipolar Disord 20:18-26
Martinez-Torteya, Cecilia; Katsonga-Phiri, Tiamo; Rosenblum, Katherine Lisa et al. (2018) Postpartum depression and resilience predict parenting sense of competence in women with childhood maltreatment history. Arch Womens Ment Health 21:777-784
Chen, Luyi; Xu, Wenli; Lee, Allen et al. (2018) The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial. EBioMedicine 35:87-96
Tapper, Elliot B; Baki, Jad; Parikh, Neehar D et al. (2018) Frailty, Psychoactive Medications, and Cognitive Dysfunction are Associated with Poor Patient-Reported Outcomes in Cirrhosis. Hepatology :

Showing the most recent 10 out of 24 publications